BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38792411)

  • 1. Hospital Readmissions in Patients Supported with Durable Centrifugal-Flow Left Ventricular Assist Devices.
    Kyriakopoulos CP; Selzman CH; Giannouchos TV; Mylavarapu R; Sideris K; Elmer A; Vance N; Hanff TC; Kagawa H; Stehlik J; Drakos SG; Goodwin ML
    J Clin Med; 2024 May; 13(10):. PubMed ID: 38792411
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors determining post-operative readmissions after left ventricular assist device implantation.
    Tsiouris A; Paone G; Nemeh HW; Brewer RJ; Morgan JA
    J Heart Lung Transplant; 2014 Oct; 33(10):1041-7. PubMed ID: 25034795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    J Heart Lung Transplant; 2019 Feb; 38(2):114-126. PubMed ID: 30691593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    Ann Thorac Surg; 2019 Feb; 107(2):341-353. PubMed ID: 30691584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends and outcomes of device-related 30-day readmissions after left ventricular assist device implantation.
    Briasoulis A; Ueyama H; Kuno T; Asleh R; Alvarez P; Malik AH
    Eur J Intern Med; 2021 Feb; 84():56-62. PubMed ID: 33039191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and Predictors of Readmissions with GI Bleeding in Patients with Left Ventricular Assist Devices.
    Shah R; Qayed E
    South Med J; 2018 Nov; 111(11):666-673. PubMed ID: 30392001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital Readmissions After Continuous-Flow Left Ventricular Assist Device Implantation: Incidence, Causes, and Cost Analysis.
    Akhter SA; Badami A; Murray M; Kohmoto T; Lozonschi L; Osaki S; Lushaj EB
    Ann Thorac Surg; 2015 Sep; 100(3):884-9. PubMed ID: 26095106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.
    Hernandez RE; Singh SK; Hoang DT; Ali SW; Elayda MA; Mallidi HR; Frazier OH; Meyers DE
    Tex Heart Inst J; 2015 Oct; 42(5):419-29. PubMed ID: 26504434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thirty-Day Readmissions After Left Ventricular Assist Device Implantation in the United States: Insights From the Nationwide Readmissions Database.
    Agrawal S; Garg L; Shah M; Agarwal M; Patel B; Singh A; Garg A; Jorde UP; Kapur NK
    Circ Heart Fail; 2018 Mar; 11(3):e004628. PubMed ID: 29519902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Readmissions after continuous flow left ventricular assist device implantation.
    Kimura M; Nawata K; Kinoshita O; Yamauchi H; Hoshino Y; Hatano M; Amiya E; Kashiwa K; Endo M; Kagami Y; Nemoto M; Ono M
    J Artif Organs; 2017 Dec; 20(4):311-317. PubMed ID: 28752193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
    Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU
    J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraplatelet reactive oxygen species, mitochondrial damage and platelet apoptosis augment non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist device.
    Mondal NK; Sorensen EN; Hiivala NJ; Feller ED; Pham SM; Griffith BP; Wu ZJ
    Platelets; 2015; 26(6):536-44. PubMed ID: 25167344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary outcomes of continuous-flow left ventricular assist devices-a systematic review.
    McNamara N; Narroway H; Williams M; Brookes J; Farag J; Cistulli D; Bannon P; Marasco S; Potapov E; Loforte A
    Ann Cardiothorac Surg; 2021 Mar; 10(2):186-208. PubMed ID: 33842214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unplanned hospital readmissions after HeartMate II implantation: frequency, risk factors, and impact on resource use and survival.
    Smedira NG; Hoercher KJ; Lima B; Mountis MM; Starling RC; Thuita L; Schmuhl DM; Blackstone EH
    JACC Heart Fail; 2013 Feb; 1(1):31-9. PubMed ID: 24621797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet glycoprotein Ibα ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices.
    Hu J; Mondal NK; Sorensen EN; Cai L; Fang HB; Griffith BP; Wu ZJ
    J Heart Lung Transplant; 2014 Jan; 33(1):71-9. PubMed ID: 24055626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive Care Unit Readmission After Left Ventricular Assist Device Implantation: Causes, Associated Factors, and Association With Patient Mortality.
    Hui J; Mauermann WJ; Stulak JM; Hanson AC; Maltais S; Barbara DW
    Anesth Analg; 2019 Jun; 128(6):1168-1174. PubMed ID: 31094784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of QRS Duration and Ventricular Pacing on Clinical and Arrhythmic Outcomes in Continuous Flow Left Ventricular Assist Device Recipients: A Multicenter Study.
    Gopinathannair R; Roukoz H; Trivedi JR; Cowger J; Bhan A; Ravichandran A; Bhat G; Birks EJ; Slaughter MS; Ahmed MM
    J Card Fail; 2019 May; 25(5):355-363. PubMed ID: 30797964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Readmissions after ventricular assist device: etiologies, patterns, and days out of hospital.
    Forest SJ; Bello R; Friedmann P; Casazza D; Nucci C; Shin JJ; D'Alessandro D; Stevens G; Goldstein DJ
    Ann Thorac Surg; 2013 Apr; 95(4):1276-81. PubMed ID: 23481701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.